Daniela Curtius

发表

The prevalence of injection-site reactions with disease-modifying therapies and their effect on adherence in patients with multiple sclerosis: an observational study

Martin Müller, A. Bont, J. Mårlind, 2011, BMC neurology.

Natalizumab Reduces Clinical and MRI Activity in Multiple Sclerosis Patients with High Disease Activity: Results from a Multicenter Study in Switzerland

N. Putzki, Ö. Yaldizli, B. Tettenborn, 2010, European Neurology.